The pharmaceutical industry, perpetually grappling with the escalating costs and protracted timelines of drug development, is witnessing a significant paradigm…
Read More
Chinese Biotechs Emerge as Global Pharma Powerhouses, Securing One-Third of Major Deal Value in 16 Months
Over the past sixteen months, Chinese-domiciled biotechnology companies have solidified their position as pivotal players in the global pharmaceutical landscape,…
Read More
A decade in the making: How functional NAMs are redefining cardiac safety assessment
The rapid acceleration of New Approach Methodologies (NAMs) in drug safety testing has, for many, appeared to be a sudden…
Read More
BioNTech Pivots Dramatically to Oncology Amidst Waning Vaccine Revenue and Federal Shift, Cutting 1,860 Jobs and Investing €16.8 Billion in Cash
The German biotechnology powerhouse BioNTech, once synonymous with its groundbreaking COVID-19 vaccine, Comirnaty, is undergoing a profound strategic transformation, shedding…
Read More
Robotic Phlebotomy Study Signals Automation Shift for Clinical Labs
A newly published multicenter clinical study marks a pivotal moment for clinical laboratories, signaling a potential paradigm shift in how…
Read More
Deloitte Report Reveals Pharma R&D Returns Surge to 7% Driven Primarily by GLP-1 Blockbusters, Raising Sustainability Concerns
A new report from Deloitte, titled "Navigating the GLP-1 boom," indicates a significant resurgence in biopharma R&D productivity, with the…
Read More
Abacus AI Emerges as a Comprehensive Solution Addressing AI Tool Sprawl and Enhancing Enterprise Workflow Automation
The burgeoning artificial intelligence market, characterized by a proliferation of specialized tools ranging from advanced chatbots and sophisticated writing assistants…
Read More
BD, Wellstar Connect Pharmacy-to-Bedside Medication Management with AI
BD, a global leader in medical technology, has announced a landmark partnership with Wellstar Health System, one of Georgia’s largest…
Read More
UCLA Researchers Advance EGFR-Targeted Drug for Glioblastoma into Clinical Testing
Researchers at UCLA have achieved a significant milestone in the arduous fight against glioblastoma, a notoriously aggressive and lethal form…
Read More
From list price to net price: How finance leaders decode real drug costs
In the complex tapestry of the healthcare industry, discussions surrounding drug pricing frequently commence and conclude with the list price.…
Read MoreYOU MAY HAVE MISSED
